[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherControl group: Patients hospitalized with COVID-19 disease who are received standard treatment ( Hydroxychloroquine 400mg daily)", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention group: Patients hospitalized with COVID-19 disease who in addition to their standard treatment ( Hydroxychloroquine 400mg daily) will be received 1000mg/day Methylprednisolone\u200e for 3 days and a stat 40 mg dose of Adalimumab.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 1807, "treatment_name": "Adalimumab+methylprednisolone", "treatment_type": "Other targeted therapies+corticosteroids", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]